Pleiotropic Functions of Nitric Oxide Produced by Ascorbate for the Prevention and Mitigation of COVID-19: A Revaluation of Pauling's Vitamin C Therapy
- PMID: 36838362
- PMCID: PMC9963342
- DOI: 10.3390/microorganisms11020397
Pleiotropic Functions of Nitric Oxide Produced by Ascorbate for the Prevention and Mitigation of COVID-19: A Revaluation of Pauling's Vitamin C Therapy
Abstract
Linus Pauling, who was awarded the Nobel Prize in Chemistry, suggested that a high dose of vitamin C (l-ascorbic acid) might work as a prevention or treatment for the common cold. Vitamin C therapy was tested in clinical trials, but clear evidence was not found at that time. Although Pauling's proposal has been strongly criticized for a long time, vitamin C therapy has continued to be tested as a treatment for a variety of diseases, including coronavirus infectious disease 2019 (COVID-19). The pathogen of COVID-19, SARS-CoV-2, belongs to the β-coronavirus lineage, which includes human coronavirus, severe acute respiratory syndrome (SARS), and Middle East respiratory syndrome (MERS). This review intends to shed new light on vitamin C antiviral activity that may prevent SARS-CoV-2 infection through the chemical production of nitric oxide (NO). NO is a gaseous free radical that is largely produced by the enzyme NO synthase (NOS) in cells. NO produced by upper epidermal cells contributes to the inactivation of viruses and bacteria contained in air or aerosols. In addition to enzymatic production, NO can be generated by the chemical reduction of inorganic nitrite (NO2-), an alternative mechanism for NO production in living organisms. Dietary vitamin C, largely contained in fruits and vegetables, can reduce the nitrite in saliva to produce NO in the oral cavity when chewing foods. In the stomach, salivary nitrite can also be reduced to NO by vitamin C secreted from the epidermal cells of the stomach. The strong acidic pH of gastric juice facilitates the chemical reduction of salivary nitrite to produce NO. Vitamin C contributes in multiple ways to the host innate immune system as a first-line defense mechanism against pathogens. Highlighting chemical NO production by vitamin C, we suggest that controversies on the therapeutic effects of vitamin C in previous clinical trials may partly be due to less appreciation of the pleiotropic functions of vitamin C as a universal bioreductant.
Keywords: COVID-19; SARS-CoV-2; antiviral activity; l-ascorbic acid: Linus Pauling; nitric oxide; nitrite; vitamin C.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Blood nitrate and nitrite modulating nitric oxide bioavailability: Potential therapeutic functions in COVID-19.Nitric Oxide. 2020 Oct 1;103:29-30. doi: 10.1016/j.niox.2020.07.005. Epub 2020 Jul 23. Nitric Oxide. 2020. PMID: 32712272 Free PMC article.
-
Vitamin C supplementation and the common cold--was Linus Pauling right or wrong?Int J Vitam Nutr Res. 1997;67(5):329-35. Int J Vitam Nutr Res. 1997. PMID: 9350474 Review.
-
In vitro studies indicate that acid catalysed generation of N-nitrosocompounds from dietary nitrate will be maximal at the gastro-oesophageal junction and cardia.Scand J Gastroenterol. 2002 Mar;37(3):253-61. doi: 10.1080/003655202317284147. Scand J Gastroenterol. 2002. PMID: 11916186
-
Enhancement of iron(II)-dependent reduction of nitrite to nitric oxide by thiocyanate and accumulation of iron(II)/thiocyanate/nitric oxide complex under conditions simulating the mixture of saliva and gastric juice.Chem Res Toxicol. 2012 Jan 13;25(1):207-15. doi: 10.1021/tx200438q. Epub 2011 Dec 28. Chem Res Toxicol. 2012. PMID: 22145785
-
Dietary foods containing nitric oxide donors can be early curators of SARS-CoV-2 infection: A possible role in the immune system.J Food Biochem. 2022 Mar;46(3):e13884. doi: 10.1111/jfbc.13884. Epub 2021 Aug 9. J Food Biochem. 2022. PMID: 34374096 Free PMC article. Review.
Cited by
-
In Silico and In Vitro Evaluation of the Molecular Mimicry of the SARS-CoV-2 Spike Protein by Common Short Constituent Sequences (cSCSs) in the Human Proteome: Toward Safer Epitope Design for Vaccine Development.Vaccines (Basel). 2024 May 14;12(5):539. doi: 10.3390/vaccines12050539. Vaccines (Basel). 2024. PMID: 38793790 Free PMC article.
References
-
- Perkins G.D., Ji C., Connolly B.A., Couper K., Lall R., Baillie J.K., Bradley J.M., Dark P., Dave C., De Soyza A., et al. Effect of noninvasive respiratory dtrategies on intubation or mortality among patients with acute hypoxemic respiratory failure and COVID-19: The RECOVERY-RS randomized clinical trial. JAMA. 2022;327:546–558. doi: 10.1001/jama.2022.0028. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous